Florida Hospital Medical Group

Orlando, Florida 32804

0 studies enrolling now · 3 studies all time

What they study most

ALK-positive Advanced NSCLC, Advanced Cholangiocarcinoma, FGFR2 Gene Mutation, Primary Generalized Epilepsy

Studies at this site

• Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures — Completed
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early